Senescence landscape in the liver following sepsis and senolytics as potential therapeutics
Aging Cell · 2025-01 · 24 (1)
DOI: 10.1111/acel.14354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 23.10.2024. Verfasst von Rupa Lavarti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Sepsis, Cellular Senescence, Senotherapeutics, Liver. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, BLRD VA, NIA NIH HHS.
Themen: Sepsis
Abstract (Originalsprache)
Senescence, caused by cell‐cycle arrest, is a hallmark of aging. Senescence has also been described in embryogenesis, wound healing, and acute injuries. Sepsis is characterized by a dysregulated host response to infection, leading to organ dysfunction and mortality. Most of the pathophysiology of human sepsis is recapitulated in the mouse model of polymicrobial sepsis, developed by cecal ligation and puncture (CLP). In this report, we demonstrate a rapid onset of cellular senescence in the liver of mice subjected to CLP‐induced sepsis, characterized by the upregulation of p21, p53, and other senescence markers, including SA‐βgal. Using RNAscope, confocal microscopy, and flow cytometry, we further confirm the emergence of p21‐expressing senescence phenotype in the liver 24 h after sepsis induction. Senescence was observed in several cell types in the liver, including hepatocytes, endothelial cells, and macrophages. We determined the landscape of senescence phenotype in murine sepsis by single‐cell sequencing, which further ascertained that this cell fate is not confined to any particular cell type but displays a heterogeneous distribution. Furthermore, we observed a significant reduction in mortality following sepsis when mice were treated with senolytics, a combination of dasatinib and quercetin, before the CLP surgery. Our experiments unequivocally demonstrated a rapid development of cellular senescence with sepsis and, for the first time, described the senescence landscape in the sepsis liver and the possible role of senescent cells in the worsening outcome following sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
- Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
ORCID-Profile: Raghavan Pillai Raju
Förderung
- NIGMS NIH HHS
- BLRD VA
- NIA NIH HHS
- U.S. Department of Veterans Affairs
- National Institute on Aging
- National Institute of General Medical Sciences
Zitieren
APA
Lavarti, R., Cai, L., Alvarez-Diaz, T., Medina-Rodriguez, T., Bombin, S., & Raju, R. P. (2025). Senescence landscape in the liver following sepsis and senolytics as potential therapeutics. Aging Cell, 24(1). https://doi.org/10.1111/acel.14354
Vancouver
Lavarti R, Cai L, Alvarez-Diaz T, Medina-Rodriguez T, Bombin S, Raju RP. Senescence landscape in the liver following sepsis and senolytics as potential therapeutics. Aging Cell. 2025;24(1). doi:10.1111/acel.14354
BibTeX
@article{Lavarti2025,
author = {Lavarti, Rupa and Cai, Lun and Alvarez-Diaz, Tatiana and Medina-Rodriguez, Thalia and Bombin, Sergei and Raju, Raghavan Pillai},
title = {Senescence landscape in the liver following sepsis and senolytics as potential therapeutics},
journal = {Aging Cell},
year = {2025},
volume = {24},
number = {1},
doi = {10.1111/acel.14354}
}
EUVIMED